Learn more about this important market by subscribing to CELL AND GENE THERAPY BUSINESS OUTLOOK, a twice-monthly publication from the leaders at Kalorama Information.
This is an exciting time for the cell and gene therapy industry. Its products are transforming the treatment of cancers and genetic diseases, as well as a host of other illnesses including autoimmune diseases, cardiovascular diseases, musculoskeletal disease, dermatological diseases and many others.
As the science rapidly advances, the industry is proceeding to standardize product manufacturing and commercialization. This includes standardized set-ups and closed automated systems. As this occurs, opportunities are arising for contract manufacturers (CMOs) to play leading roles in this process.